๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy

โœ Scribed by C.D. Binnie; R.M.C. Debets; M. Engelsman; J.W.A. Meijer; H. Meinardi; J. Overweg; A.W. Peck; A. Van Wieringen; W.C. Yuen

Book ID
108022752
Publisher
Elsevier Science
Year
1989
Tongue
English
Weight
502 KB
Volume
4
Category
Article
ISSN
0920-1211

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A randomised double-blind placebo-contro
A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures
โœ P. Loiseau; A.W.C. Yuen; B. Duchรฉ; T. Mรฉnager; M.C. Arnรฉ-Bรจs ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 874 KB

Efficacy and safety of lamotrigine (LTG) as add-on therapy was assessed in a randomised double-blind placebo-controlled trial of this drug in 23 adult patients with refractory partial seizures. Fifteen patients showed an improvement on LTG treatment, with a greater than 50% decrease in total seizure

A randomized, double-blind, placebo-cont
A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients
โœ Fabrizio Stocchi; Rupam Borgohain; Marco Onofrj; Anthony H.V. Schapira; Mohit Bh ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 446 KB ๐Ÿ‘ 2 views

## Abstract Safinamide is an ฮฑโ€aminoamide with both dopaminergic and nondopaminergic mechanisms of action evaluated as an addโ€on to dopamine agonist (DA) therapy in earlyโ€stage PD. In this 24โ€week, doubleโ€blind study, patients with early PD receiving a stable dose of a single DA were randomized to